Panacea Index Logo

Command Palette

Search for a command to run...

Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia.

Archives of internal medicine
September 1, 1990
E G Levin et al. (6 authors)
Clinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether psyllium, as an adjunct to a prudent diet, could effectively and safely reduce cholesterol levels in individuals with moderate hypercholesterolemia.

Results Summary

Psyllium supplementation (5.1 g twice daily) significantly reduced total cholesterol by 5.6% and LDL cholesterol by 8.6% compared to placebo, with no substantial changes in HDL cholesterol or triglycerides. Compliance was high (>95%), and no adverse effects were reported, suggesting psyllium is a safe and useful adjunct to a prudent diet for cholesterol management.

Population

Individuals with moderate hypercholesterolemia (specific demographics not detailed).

Effective Dosage

5.1 g of psyllium twice daily.

Duration

16 weeks.

Interactions

None mentioned.

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
psyllium
decrease
total cholesterol level
patients with moderate hypercholesterolemia
5.6%
decreased
#1
psyllium
decrease
low-density lipoprotein cholesterol level
patients with moderate hypercholesterolemia
8.6%
decreased
#2
placebo (cellulose)
no change
total cholesterol level
patients with moderate hypercholesterolemia
-
unchanged
#3
placebo (cellulose)
no change
low-density lipoprotein cholesterol level
patients with moderate hypercholesterolemia
-
unchanged
#4
prudent diet
decrease
high-density lipoprotein cholesterol level
patients with moderate hypercholesterolemia
-
decreased
#5
-
increase
high-density lipoprotein cholesterol level
patients with moderate hypercholesterolemia
-
returned to near-baseline values
#6
psyllium
no change
plasma triglyceride levels
patients with moderate hypercholesterolemia
-
did not change substantially
#7
placebo (cellulose)
no change
plasma triglyceride levels
patients with moderate hypercholesterolemia
-
did not change substantially
#8
Abstract

The effects of the administration of 5.1 g of psyllium or placebo (cellulose) twice daily for 16 weeks were compared as adjuncts to a prudent diet in the management of moderate hypercholesterolemia in a parallel, double-blind study. Psyllium decreased the total cholesterol level by 5.6% and the low-density lipoprotein cholesterol level by 8.6%, whereas the levels were unchanged in the placebo group. The high-density lipoprotein cholesterol level decreased during the diet stabilization period in both groups and returned to near-baseline values by week 16. Plasma triglyceride levels did not change substantially in either group. Subject compliance to treatment was greater than 95%. These data suggest that psyllium hydrophilic mucilloid in a twice-daily regimen may be a useful and safe adjunct to a prudent diet in the treatment of moderate hypercholesterolemia.

Medical Subject Headings (MeSH)
CelluloseCholesterolCholesterol, HDLCholesterol, LDLClinical Trials as TopicDouble-Blind MethodFemaleHumansHypercholesterolemiaMaleMiddle AgedPsyllium
Study Links
PubMed ID2203322
Quality Scores
Safety80
Efficacy70/10
Quality80/10
Citation Metrics
Total Citations58
Citations/Year1.7
Relative Citation Ratio2.55
NIH Percentile81.2%
Research Impact Scores
APT Score0.75
Weight Score0.35
Normalized Score0.76
Related Supplements